Plain-English translation of NCT05911932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why some people develop dementia—including Alzheimer's disease, frontotemporal dementia, and Lewy body dementia. By studying your genes through a simple blood test, they hope to find genetic patterns that cause these diseases and help develop better treatments in the future.
Many cases of dementia run in families, but doctors don't yet know which specific genes are responsible. This study aims to close that gap by identifying genetic risk factors that could lead to new ways to prevent or treat these conditions.
You likely qualify if…
You likely don't qualify if…
You will visit a cognitive clinic and have a blood sample drawn by a healthcare professional—a quick, routine procedure similar to a standard blood test. The researchers will use your blood sample to analyze your genes and look for patterns related to dementia. There are no ongoing visits or medications involved.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Canada
Enrollment target
~1,000 participants
Started
October 2023
Primary completion
August 2038
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sarah Jesso
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.